Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas

Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2009) L. Jilaveanu et al.   CLINICAL CANCER RESEARCH

Effect of Tyrosine Kinase Inhibition by Imatinib Mesylate on Mast Cell Tumors in Dogs

(2009) M. Isotani et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors

(2009) Chi-Ho Yu et al.   Journal of Veterinary Science

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

(2009) Carlos A Torres-Cabala et al.   MODERN PATHOLOGY

Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2009) S. E. Woodman et al.   MOLECULAR CANCER THERAPEUTICS

Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone

(2008) Joshua D Webster et al.   BMC Veterinary Research

KIT Gene Mutations and Copy Number in Melanoma Subtypes

(2008) C. Beadling et al.   CLINICAL CANCER RESEARCH

An Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma

(2008) S. Sabattini et al.   JOURNAL OF COMPARATIVE PATHOLOGY